Theseus Pharmaceuticals Statistics
Total Valuation
Morningstar has a market cap or net worth of $10.97 billion. The enterprise value is $11.46 billion.
| Market Cap | 10.97B |
| Enterprise Value | 11.46B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
Morningstar has 42.18 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 42.18M |
| Shares Outstanding | 42.18M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | -1.39% |
| Owned by Insiders (%) | 41.59% |
| Owned by Institutions (%) | 62.18% |
| Float | 24.61M |
Valuation Ratios
The trailing PE ratio is 27.65 and the forward PE ratio is 26.34.
| PE Ratio | 27.65 |
| Forward PE | 26.34 |
| PS Ratio | 4.72 |
| Forward PS | 4.30 |
| PB Ratio | 6.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.14 |
| P/OCF Ratio | 20.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.72, with an EV/FCF ratio of 29.40.
| EV / Earnings | 28.36 |
| EV / Sales | 4.88 |
| EV / EBITDA | 20.72 |
| EV / EBIT | 25.02 |
| EV / FCF | 29.40 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.13 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | 2.65 |
| Interest Coverage | 10.91 |
Financial Efficiency
Return on equity (ROE) is 26.51% and return on invested capital (ROIC) is 11.12%.
| Return on Equity (ROE) | 26.51% |
| Return on Assets (ROA) | 8.14% |
| Return on Invested Capital (ROIC) | 11.12% |
| Return on Capital Employed (ROCE) | 16.91% |
| Revenue Per Employee | $211,764 |
| Profits Per Employee | $36,455 |
| Employee Count | 11,085 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Morningstar has paid $117.20 million in taxes.
| Income Tax | 117.20M |
| Effective Tax Rate | 22.48% |
Stock Price Statistics
The stock price has decreased by -13.91% in the last 52 weeks. The beta is 0.96, so Morningstar's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -13.91% |
| 50-Day Moving Average | 295.74 |
| 200-Day Moving Average | 312.62 |
| Relative Strength Index (RSI) | 23.37 |
| Average Volume (20 Days) | 351,141 |
Short Selling Information
The latest short interest is 623,335, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 623,335 |
| Short Previous Month | 487,441 |
| Short % of Shares Out | 1.48% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, Morningstar had revenue of $2.35 billion and earned $404.10 million in profits. Earnings per share was $9.41.
| Revenue | 2.35B |
| Gross Profit | 1.43B |
| Operating Income | 458.10M |
| Pretax Income | 317.20M |
| Net Income | 404.10M |
| EBITDA | 553.10M |
| EBIT | 458.10M |
| Earnings Per Share (EPS) | $9.41 |
Balance Sheet
The company has $541.60 million in cash and $1.03 billion in debt, giving a net cash position of -$492.40 million or -$11.67 per share.
| Cash & Cash Equivalents | 541.60M |
| Total Debt | 1.03B |
| Net Cash | -492.40M |
| Net Cash Per Share | -$11.67 |
| Equity (Book Value) | 1.61B |
| Book Value Per Share | 38.28 |
| Working Capital | 121.30M |
Cash Flow
In the last 12 months, operating cash flow was $535.30 million and capital expenditures -$145.50 million, giving a free cash flow of $389.80 million.
| Operating Cash Flow | 535.30M |
| Capital Expenditures | -145.50M |
| Free Cash Flow | 389.80M |
| FCF Per Share | $9.24 |
Margins
Gross margin is 60.94%, with operating and profit margins of 19.52% and 17.21%.
| Gross Margin | 60.94% |
| Operating Margin | 19.52% |
| Pretax Margin | 22.21% |
| Profit Margin | 17.21% |
| EBITDA Margin | 23.56% |
| EBIT Margin | 19.52% |
| FCF Margin | 16.61% |
Dividends & Yields
This stock pays an annual dividend of $1.82, which amounts to a dividend yield of 0.70%.
| Dividend Per Share | $1.82 |
| Dividend Yield | 0.70% |
| Dividend Growth (YoY) | 12.35% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 19.35% |
| Buyback Yield | 0.23% |
| Shareholder Yield | 0.93% |
| Earnings Yield | 3.68% |
| FCF Yield | 3.55% |
Analyst Forecast
The average price target for Morningstar is $361.67, which is 39.08% higher than the current price. The consensus rating is "Buy".
| Price Target | $361.67 |
| Price Target Difference | 39.08% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 8.06% |
| EPS Growth Forecast (5Y) | 12.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Morningstar has an Altman Z-Score of 5.91 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.91 |
| Piotroski F-Score | 8 |